benzylpiperazine bzp substance often used recreational drug known euphoriant stimulant properties several studies conducted found effects bzp similar amphetamine although bzps dosage roughly times higher adverse effects reported following use including acute psychosis renal toxicity deaths piperazine derivatives extremely rare least one death apparently due bzp sale banned several countries including australia canada new zealand united states republic ireland united kingdom bulgaria romania parts bzp first synthesized burroughs wellcome company often claimed originally synthesized potential antihelminthic antiparasitic agent use farm synthesis thought predate interest piperazines even majority early work piperazines investigations potential use anthelmintics earliest clinical trials literature relating piperazine articles british medical journal discovered bzp side effects largely abandoned worm treatmentcitation needed next appears literature investigated potential antidepressant rejected research reported bzp amphetaminelike effects liable abuse study suggested bzp placed statutory control similar regulating use united states drug enforcement administration noted recreationally used also reported bzp used adulterant illicit drugs around use increased soon followed legislative control europe united states new zealand initially legal restricted later reclassified class c due new evidence widely used reclassification estimated million pills sold new zealand bzp often mixed tfmpp claimed safer alternative illicit street also used adulterant substitute similar effects sometimes marketed ecstasy colloquial term bzp also used prohibited horse racing bzp piperazine derivative comes either hydrochloride salt free base hydrochloride salt white solid base form slightly yellowishgreen liquid bzp base corrosive causes bzp often marketed ostensibly dietary supplement avoid meeting stricter laws apply medicines drugs despite fact bzp dietary value late misuse drugs act ensured longer classified marketed dietary supplement new retailers claim bzp natural product describing pepper extract herbal high fact drug entirely found occur bzp shown mixed mechanism action acting serotonergic dopaminergic receptor systems similar fashion bzp amphetaminelike actions serotonin reuptake transporter increase serotonin concentrations extracellular fluids surrounding cell thereby increasing activation surrounding serotonin bzp lower potency effect noradrenaline reuptake transporter dopamine reuptake bzp high affinity action antagonist receptor like yohimbine inhibits negative feedback causing increase released another lists bzps release dat net sert ie measure potency release neurotransmitters via bzps affinity dopamine norepinephrine serotonin transporters respectivelywhereby transporter induced shuttle neurotransmitters neurons deposit synaptic gap comparison values listed damphetamine dmethamphetamine show similar datnet affinity ratio well minor sert activity suggests bzp possesses similar activity two aforementioned drugs dosed higher due lower potency rather serotonergic substituted amphetamines like mdma bzp also acts nonselective serotonin receptor agonist wide variety serotonin binding receptors may explain mild hallucinogenic effects high doses partial agonist antagonist effects receptors may explain bzps peripheral side effects receptor expressed densely gut binding receptors may explain common side effect headaches receptor known involved development migraine effects bzp largely similar one study finding former amphetamine addicts unable distinguish dextroamphetamine bzp administered study shown mixtures bzp piperazine drugs tfmpp share certain pharmacodynamic traits upon ingestion mg mg bzp user may experience following initial later research bzps tolerance anecdotal evidence online sources claim tolerance central action bzp develop due tiredness associated bodys recovery stimulants bzp uncommon users able sustain weeklong sympathomimetic stimulants significant side effects associated bzp use reportedly produces insomnia mild severe hangover drug effect wears majority toxic effects information came study recorded presentations associated party pill use emergency department christchurch hospital new zealand fourteen toxic seizures recorded two patients lifethreatening toxicity status epilepticus severe respiratory metabolic results study others like showed bzp cause unpredictable serious toxicity data dosage collection reliant self reporting drug users may result underreporting overreporting complicating factors like frequent presence alcohol major side effects include dilated pupils blurred vision dryness mouth extreme alertness pruritus confusion agitation tremor extrapyramidal symptoms dystonia akathisia headache dizziness anxiety insomnia vomiting chest pain hallucinations paresthesia tachycardia hypertension palpitations collapse hyperventilation sweating hyperthermia problems urine severe toxic effects include psychosis adverse psychiatric renal respiratory serotonin blood benzylpiperazine concentrations measured either confirm clinical intoxication part medicolegal death ingestion piperazine derivatives alone rarely causes retrospective study carried auckland emergency department found bzp presentations made minor contribution overdose database cases producing significant one death attributed ingestion bzp alone case blood concentration measured combined alcohol illicit drugs tfmpp mdma multiple deaths combination bzp mdma ingested dj nearly resulted death put induced coma later another case zurich taken bzp mdma died massive cerebral edema hours hospital bzp found physically addictive users bzp say could stop want studies undertaken animals indicated bzp substitute methamphetamine addicted rats although onetenth potent produces correspondingly weaker addictive bzp banned australia austria canada denmark estonia france germany greece ireland italy japan malta poland sweden united bzp controlled un convention compounds legal throughout world although countries use restricted pharmaceutical manufacturing recreational use bzp banned australian states victoria last state legal changed classification september bzp piperazine analogs become illegal federal schedules enacted australian states territories canada benzylpiperazine salts benzylpiperazine classified schedule iii controlled substances controlled drugs substances benzylpiperazine subject european monitoring centre drugs drug addiction emcdda risk assessment determine determine control throughout european union risk assessment came result joint europol emcdda report concluded bzp needs looked detail report published june concluded use bzp lead medical problems even long effects still unknown taking concession basis european commission asked council place bzp control un convention psychotropic march eu requested countries place bzp control within based recommendation eacd new zealand government passed legislation placed bzp along piperazine derivatives tfmpp mcpp pfpp meopp mbzp class c misuse drugs act ban intended come effect new zealand december law change go following year sale bzp listed piperazines became illegal new zealand april amnesty possession usage drugs effect october point became completely piperazine salts piperazine classified prescription medicines uk products containing salts piperazine would licensable medicines consequently anyone manufacturing supplying legally must hold relevant licenses bzp salt piperazine mislabelling bzp products containing piperazine blend resulted prosecutions suppliers uk medicines healthcare products regulatory agency although none may home office announced plans ban launched consultation october announced december bzp related piperazines would class c drugs misuse drugs drug federally classified schedule controlled substance united states following report dea incorrectly stated bzp times potent fact bzp ten times less potent also illegal state level florida oklahoma vermont diphenylmethylpiperazines also similar benzylpiperazines httpsenwikipediaorgwikibenzylpiperazine